GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the escherichia COLI transcriptional repressor ascg

Analyse Crystal structure of the escherichia COLI transcriptional repressor ascg in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3BRQ
Type
protein
Length
548 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Hth-type transcriptional regulator ascg
UniProt
P24242
Ligands
FRU, NA, SO4
Pockets
1 · best druggability 0.79

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHth-type transcriptional regulator ascgprotein27144% helix, 16% strandP24242
BHth-type transcriptional regulator ascgprotein27743% helix, 18% strandP24242

Ligands and binding sites

  • FRU · beta-D-fructofuranose · sugar · chains A
  • NA · Sodium ion · metal · chains B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19320.790.8171FRU, SO4

Interfaces

1 interface between chains.

  • A–B · 1869 Ų buried · 22 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 18 modified (engineered).

Compared structures

  • 3BRQ · Crystal structure of the Escherichia coli transcriptional repressor ascG · the same entry in another collection · chain A against A, TM-score 1.00
  • P24242 · AlphaFold monomer V2.0 prediction for hth-type transcriptional regulator ascg (P24242) · a predicted model of the same protein · chain B against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.